Insight Advisors, LLC Bristol Myers Squibb CO Transaction History

Insight Advisors, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	SELL	$47.98 - $54.4 $2,303 - $2,611	-48 Reduced 1.11%	4,271 $231,000
Q4 2023 Jan 23, 2024	SELL	$48.48 - $57.85 $12,459 - $14,867	-257 Reduced 5.62%	4,319 $221,000
Q3 2023 Nov 07, 2023	SELL	$57.89 - $64.73 $100,207 - $112,047	-1,731 Reduced 27.45%	4,576 $265,000
Q2 2023 Aug 07, 2023	BUY	$63.71 - $70.74 $2,420 - $2,688	38 Added 0.61%	6,307 $403,000
Q1 2023 May 03, 2023	SELL	$65.71 - $74.53 $12,747 - $14,458	-194 Reduced 3.0%	6,269 $434,000
Q4 2022 Feb 21, 2023	BUY	$68.48 - $81.09 $8,080 - $9,568	118 Added 1.86%	6,463 $464,000
Q3 2022 Dec 12, 2022	BUY	$0.13 - $76.84 $8 - $4,994	65 Added 1.04%	6,345 $451,000
Q2 2022 Aug 11, 2022	SELL	$72.62 - $79.98 $17,501 - $19,275	-241 Reduced 3.7%	6,280 $453,000
Q1 2022 May 13, 2022	SELL	$61.48 - $73.72 $6,025 - $7,224	-98 Reduced 1.48%	6,521 $476,000
Q4 2021 Feb 09, 2022	SELL	$53.63 - $62.52 $38,613 - $45,014	-720 Reduced 9.81%	6,619 $413,000
Q3 2021 Nov 12, 2021	BUY	$59.17 - $69.31 $3,017 - $3,534	51 Added 0.7%	7,339 $435,000
Q2 2021 Aug 12, 2021	SELL	$61.91 - $67.42 $57,142 - $62,228	-923 Reduced 11.24%	7,288 $496,000
Q1 2021 May 17, 2021	BUY	$59.34 - $66.74 $24,685 - $27,763	416 Added 5.34%	8,211 $513,000
Q4 2020 Feb 12, 2021	BUY	$57.74 - $65.43 $450,083 - $510,026	7,795 New	7,795 $484,000

2,405

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $114B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Insight Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Insight Advisors, LLC with notifications on news.